RGC Stock Performance and Key Statistics

RGC has a current P/E ratio of -6317.33

The RGC stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 4658.72.

RGC's price-to-free-cashflow (P/FCF) ratio is N/A, an indicator that is currently being trending upward.

Based on RGC's recent bid, its distance from 20 days simple moving average is 81.66%. It is 149.8% apart from 50 days simple moving average, and it is 211.61% apart from 200 days simple moving average.

The 52-week high for RGC is $83.60 which is -45.23% away from the current price level whereas the distance of that from the 52-week low of $0.09 stands at 49,248.27%.

The performance of RGC stock was not encouraging with most of its significant price indicators in green. Regencell Bioscience Holdings Limited(NASDAQ: RGC) shares have moved upward +10.55% or $4.37 in the latest trading session and have gained 97.24% year-to-date (YTD). The stock has gained nearly 32,514.17% over the past year. After moving 106.58% over the trailing 3-month period, the stock is 138.05% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 97.24% a week and 155.05% a month.

The current 14-day RSI for RGC stock is 70.63. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Regencell Bioscience Holdings Limited (RGC) has a 14-day ATR of 7.37.

After closing at $41.42 with 494.49M of its shares outstanding, the current enterprise value of RGC is roughly 65.26M.

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is up 32,514.17% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 12.34%. RGC stock price is also up 97.24% on its value in year-to-date trading.

The number outstanding shares of RGC is 494.49M, and of these 92.4% shares are freely available for trading. On average, RGC stock has traded 2.27M shares per day for the past 10 days. A total of 1.56M shares changed hands during the last trading session with the average session volume of 354.58K shares.